NCT07632742 · Northwestern University
Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial
What this study is about
The objective of this study is to compare the Magneto 150 holmium laser to the current MOSES 2.0 technology to see if there is a benefit in decreased hemostasis time intraoperatively.
View original scientific description
The objective of this study is to compare the Magneto 150 holmium laser to the current MOSES 2.0 technology to see if there is a benefit in decreased hemostasis time intraoperatively.
Interventions
DEVICE
Magneto 150 holmium laser
The HoLEP procedure will be performed using the Quanta Magneto 150 holmium laser
DEVICE
Moses 2.0 holmium laser
The HoLEP procedure will be performed using the Moses 2.0 holmium laser
Primary outcome measures
Mean hemostasis time
Time frame: During surgery
Overall intraoperative hemostasis time
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Undergoing HoLEP for the treatment of bothersome lower urinary tract symptoms
- Internet access and a device to complete postoperative questionnaires (smartphone, tablet, laptop or desktop computer)
Exclusion criteria
- Patients who lack decisional capacity
- Patients unable to read/speak English
- Patients who are on a blood thinner (anticoagulation medication)
- Patients who do not have internet access to complete postoperative surveys
Where
- Chicago, Illinois
Collaborators
Cook Group Incorporated
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Jun 8, 2026 · Source of record for eligibility and locations